濮阳东方线上医生咨询濮阳东方医院看病贵不贵,濮阳东方技术非常专业,濮阳东方医院男科治疗早泄价格偏低,濮阳东方医院男科割包皮手术安全不,濮阳东方男科口碑怎么样,濮阳东方妇科医院技术安全放心,濮阳东方妇科医院很靠谱

In another sign of the times for retail, Lowe's is closing 51 North American stores.The home improvement chain said Monday that locations are underperforming and the decision will help the hardware chain focus on its most profitable stores and "improve the overall health of its store portfolio."Lowe's (LOW) is shutting down 20 stores in the U.S. and 31 in Canada. The company said that a "majority" of the shuttered stores are within 10 miles of another Lowe's location.The stores will be closed before Feb. 1, 2019. The company will try to find jobs at nearby stores for its employees affected by the closings."We believe our people are the foundation of our business and essential to our future growth," said CEO Marvin R. Ellison.Lowe's is struggling to keep up with its larger rival Home Depot. Ellison, who joined the company in May, has already made some big strategic decisions, including closing all of its Orchard Supply Hardware stores and slashing inventory at its Lowe's stores.The company cut its sales and profit outlook for the year. Its next earnings report is on November 20. 1102

Hundreds of museums across the country are struggling financially. Many were shut down for long periods of time during stay-at-home orders to slow the spread of the coronavirus. Some are still not ready to reopen. "We're targeting to reopen next year. Hopefully, we will sit back and recover and be able to think through and make sure everything will be safe for everybody," said Lily Birmingham, the director of the San Diego Chinese Historical Museum. Birmingham's museum, like many others, shut down in March because of shelter-in-place restrictions."We have very little funding to begin with so with the closure of the museum, we can not raise funding. We couldn't get admission funding so we had to lay off our employees. We now rely on volunteers, so it's very difficult. Funding is always difficult for museums. We're a non-profit organization," said Birmingham.Recently, The American Alliance of Museums surveyed more than 750 museums nationwide. From large to small and in urban and rural communities. What they found was that nearly one-third of them may not survive this pandemic."Back in March, I kind of speculated that it might be 25-30% of museums that would not make it through an extended financial crisis and indeed the survey did confirm our worst fears that one in three museums say there is a significant risk for having to close permanently," said Laura Lott, the President and CEO of the American Alliance of Museums. Lott says most museums make the majority of their money from ticket sales, renting their space for events and sales from their gift shops and cafes. Lott says museums have three major impacts on their communities, the first is economic."Museums contribute more to the economy than we might imagine. Nationally it's about billion that museums contribute to the national GDP across the country. They employ 750,000 people and pay billion in tax revenue at the state, federal and local level, even though most are non-profits," explained Lott.The second impact is on education, as they host numerous schools for field trips. Lott says the third impact museums have is they protect our cultural heritage. "Each museum is unique. It holds unique artifacts and stories that we’ve chosen to preserve and protect for future generations and if those museums go away, they're likely to be gone forever," said Lott.For the San Diego Chinese Historical Museum, historians have been collecting items dating back more than 100 years, preserving history of when Chinese immigrants first came to California. "There's a couple things people can do to help museums right now. People need to really contact their legislators and let them know why their museums are important to them and advocate that museums be included in any financial relief at all levels; the federal, state and local levels," said Lott."It could be monetary, of course, is the best. Volunteer hours or just show the appreciation. Show the concern and care so we know people love our museum. So, there are different ways to show the appreciation," said Birmingham. Lott says any bit of support will make a difference for many museums so they can continue to preserve history for years to come. 3202

House Majority Leader Kevin McCarthy plans to introduce legislation this week that will fully fund President Donald Trump's proposed wall along the U.S.-Mexico border with a whopping .4 billion price tag, a spokesperson for the California Republican told CNN on Tuesday.The bill is still in the drafting process but is expected to be released within the next few days in the pro-forma session this week. The House remains in recess until mid-November, after the midterm elections, so the body would not consider the legislation for another month or so. Even with a Republican-controlled Capitol Hill and White House, any proposal to fully fund Trump's signature campaign pledge of a border wall would have a difficult pathway to passing both chambers of Congress, given the threshold for such legislation and the narrow margin of control in the Senate.The legislation comes as McCarthy is headed to the U.S.-Mexico border on Wednesday for a tour and briefing by the Department of Homeland Security and as the California congressman continues to push to succeed Speaker Paul Ryan when the Wisconsin Republican departs in January.Mccarthy is not the only House Republican to express interest in leading the caucus. Majority Whip Steve Scalise of Louisiana and House Freedom Caucus co-founder Jim Jordan of Ohio have talked about pursuing the top House GOP spot, and both are traditionally affiliated with the more conservative side of the caucus members. Scalise has said he would not run to lead the party if McCarthy does, but Jordan has already announced his intention to seek the position.McCarthy, who has allied himself closely with Trump in the last two years, is working on the border wall bill by himself at this point, with no cosponsors. 1757

Hoverboards are once again the target for recalls, as the Consumer Product Safety Commission issued recalls Tuesday on seven models for potential fire hazard. According to the CPSC, the seven recalled hoverboard models have lithium-ion battery packs that can overheat, posing a risk of smoking, catching fire and/or exploding.Nearly 13,000 units are covered by Tuesday's recall. The most popular model was the iLive Self-Balancing Hoverboard, which sold for between 0 and 0 at various Ace Hardware and hh gregg stores nationwide, Heartland America catalogs and online at AceHardware.com and hhgregg.com.The CPSC recommends consumers immediately stop using the recalled hoverboards and contact the manufacture receive a full refund or store credit.To see a list of recalled hoverboards, click here.  852

How accurate are the coronavirus tests used in the U.S.?Months into the outbreak, no one really knows how well many of the screening tests work, and experts at top medical centers say it is time to do the studies to find out.When the new virus began spreading, the Food and Drug Administration used its emergency powers to OK scores of quickly devised tests, based mainly on a small number of lab studies showing they could successfully detect the virus.That’s very different from the large patient studies that can take weeks or months, which experts say are needed to provide a true sense of testing accuracy.The FDA’s speedy response came after it was initially criticized for delaying the launch of new tests during a crisis and after the Centers for Disease Control and Prevention stumbled in getting its own test out to states.But with the U.S. outbreak nearly certain to stretch on for months or even years, some experts want the FDA to demand better evidence of the tests’ accuracy so doctors know how many infections might be missed.There have been more than 2 million confirmed coronavirus cases in the U.S. and more than 115,000 deaths, according to data compiled by Johns Hopkins University. Cases in nearly half of U.S. states are rising.In recent weeks, preliminary findings have flagged potential problems with some COVID-19 tests, including one used daily at the White House. Faulty tests could leave many thousands of Americans with the incorrect assumption that they are virus-free, contributing to new flare-ups of the disease as communities reopen.“In the beginning, the FDA was under a lot of pressure to get these tests onto the marketplace,” said Dr. Steven Woloshin of Dartmouth College, who wrote about the issue in the New England Journal of Medicine last week. “But now that there are plenty of tests out there, it’s time for them to raise the bar.”The FDA said in a statement that it has already asked multiple test makers to do follow-up accuracy studies, although it didn’t say for how many of the more than 110 authorized screening tests. The agency also said it is tracking reports of problems. Accuracy has also been an issue with blood tests that look for signs of past infections.No screening test is 100% accurate. So details on accuracy are routinely provided for tests of all types, including seasonal flu, hepatitis, HIV and cancers. For example, rapid flu tests are known to miss 20% or more of all cases, a factor doctors weigh when treating patients who have symptoms but test negative.For now, most COVID-19 tests in the U.S. don’t give data on real-world performance, including how often the tests falsely clear patients of infection or falsely detect the virus. That information is lacking for all but a few of the roughly 80 commercial screening tests available, according to an Associated Press review.The government’s emergency authorization process “requires a lower level of evidence,” the agency said. Makers need only show that a test “may be effective” instead of the usual requirement to demonstrate “safety and effectiveness.” They would have to meet that higher threshold once the U.S. government declares the emergency over.Many of the commercial test makers submitted results from 60 samples, the minimum number required and mostly used lab-produced specimens of the virus. The FDA now recommends the use of nasal swabs or other real samples from people screened for coronavirus.Experts say larger patient studies patients are needed to assess a test’s true performance.Lab testing bears little resemblance to actual — sometimes imperfect — conditions at hospitals, clinics and testing sites noted Dr. Robert Kaplan of Stanford University.“You’re testing people in parking lots, the patients themselves are extremely anxious and often unable to follow instructions,” said Kaplan, a former associate director of the National Institutes of Health.Kaplan and others say those differences could explain why some tests are not performing as expected.Last month, the FDA warned doctors of a potential accuracy problem with Abbott Laboratories’ rapid ID Now test, which delivers results in roughly 15 minutes. The test has been lauded by President Donald Trump and used to screen the president, his staff and visitors to the White House.The FDA alert followed a preliminary report by New York University that found Abbott’s test missed between a third to one-half of infections caught by a rival test in patients screened for the virus.Abbott rejected the findings, saying the researchers did not follow the instructions for using its test. The company pointed to alternate patient studies, including its own, that have found the test successfully detects between 91% and 95% or more of virus cases when compared to other tests.But similar problems with ID NOW’s accuracy have been flagged in preliminary reports by researchers at Stanford University, Loyola University and the Cleveland Clinic.For now, the FDA is requiring Abbott to conduct follow-up studies in several different patient groups.The FDA’s emergency standards “are still high but there is a significant difference in the body of work that what would go into a submission under the normal process,” said Abbott vice president John Hackett. “Our normal process takes years to bring these out.”Requiring bigger studies of all coronavirus tests could provide valuable information, but it could also strain the FDA’s already stretched staff and resources, said Dr. Daniel Schultz, former director of the FDA’s medical device center.Dr. Colin West of the Mayo Clinic worries doctors and patients have put too much confidence in the current crop of tests, when an unknown number of patients with COVID-19 are likely receiving false negative results.Even a modest error rate can have grave consequences during an outbreak like COVID-19. West gives the example of a test that is 95% accurate at detecting the virus and is used on 1 million people. That would still result in 50,000 people being incorrectly told that they don’t have the virus.“The negative test does not mean that I’m off the hook,” West said. “We just need to maintain that level of vigilance until we have a better sense of how good these tests really can be.”___Follow Matthew Perrone on Twitter: @AP_FDAwriter.___Follow AP pandemic coverage at http://apnews.com/VirusOutbreak and https://apnews.com/UnderstandingtheOutbreak.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 6604